18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in18F-FDG avidity according to site involvement-Reference-Cited by-同舟云学术

18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in18F-FDG avidity according to site involvement

Published:2015-11-06 Issue:12 Volume:56 Page:3288-3294
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Park Seol Hoon,Lee Jong Jin,Kim Hye Ok,Lee Dong Yun,Suh Cheolwon,Jung Hwoon-Yong,Choi Kee Don,Kim Do Hoon,Huh Jooryung,Ryu Jin-Sook

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1030640

Reference32 articles.

1. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed

2. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Applications of PET/MR: Part II: Clinical Applications II;Canadian Association of Radiologists Journal;2024-06-05

2. Chemokine receptor–targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [18F]FDG;European Journal of Nuclear Medicine and Molecular Imaging;2023-11-09

3. Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma;Blood;2023-04-13

4. Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings;Blood;2023-04-13

5. Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease;Mini-Reviews in Medicinal Chemistry;2023-04